{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:55:39Z","timestamp":1790787339500,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"DOI":"10.3389\/fbioe.2020.574007","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T05:48:34Z","timestamp":1600235314000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Extracellular Vesicles-Mimetic Encapsulation Improves Oncolytic Viro-Immunotherapy in Tumors With Low Coxsackie and Adenovirus Receptor"],"prefix":"10.3389","volume":"8","author":[{"given":"Yonghui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41577-018-0014-6","article-title":"Integrating oncolytic viruses in combination cancer immunotherapy.","volume":"18","author":"Bommareddy","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B2","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1023\/A:1025714412337","article-title":"PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route.","volume":"20","author":"Cheng","year":"2003","journal-title":"Pharm. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/gt.2011.37","article-title":"Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rbeta2 or IL-18Ralpha.","volume":"18","author":"Choi","year":"2011","journal-title":"Gene Ther."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067512","article-title":"Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-gamma- and TNF-alpha-co-producing T cell-mediated antitumor immunity.","volume":"8","author":"Choi","year":"2013","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1089\/104303402760372972","article-title":"PEGylation of E1-Deleted adenovirus vectors allows significant gene expression on readministration to liver.","volume":"13","author":"Croyle","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"B6","first-page":"813","article-title":"Efficient oncolysis by a replicating Adenovirus (Ad) in vivo is critically dependent on tumor expression of primary ad receptors.","volume":"61","author":"Douglas","year":"2001","journal-title":"Cancer Res."},{"key":"B7","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system.","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus.","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/gt.2013.40","article-title":"Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer.","volume":"20","author":"Freytag","year":"2013","journal-title":"Gene Ther."},{"key":"B10","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/JVI.70.4.2116-2123.1996","article-title":"Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.","volume":"70","author":"Gall","year":"1996","journal-title":"J. Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jconrel.2018.05.015","article-title":"Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment.","volume":"283","author":"Garofalo","year":"","journal-title":"J. Control. Release"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/v10100558","article-title":"Systemic administration and targeted delivery of immunogenic oncolytic adenovirus encapsulated in extracellular vesicles for cancer therapies.","volume":"10","author":"Garofalo","year":"","journal-title":"Viruses"},{"key":"B13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jconrel.2018.12.022","article-title":"Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice.","volume":"294","author":"Garofalo","year":"2019","journal-title":"J. Control. Release"},{"key":"B14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.it.2017.11.006","article-title":"Antitumor benefits of antiviral immunity: an underappreciated aspect of oncolytic virotherapies.","volume":"39","author":"Gujar","year":"2018","journal-title":"Trends Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1016\/j.biomaterials.2014.05.032","article-title":"Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo.","volume":"35","author":"Gyorgy","year":"2014","journal-title":"Biomaterials"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/srep15636","article-title":"Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using (99m)Tc-HMPAO.","volume":"5","author":"Hwang","year":"2015","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1532763","article-title":"Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model.","volume":"8","author":"Kuryk","year":"2019","journal-title":"OncoImmunology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1016\/j.biomaterials.2014.03.060","article-title":"Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression.","volume":"35","author":"Lee","year":"2014","journal-title":"Biomaterials"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/sj.cgt.7700237","article-title":"Enhancement of adenoviral transduction with polycationic liposomes in vivo.","volume":"7","author":"Lee","year":"2000","journal-title":"Cancer Gene Ther."},{"key":"B21","first-page":"325","article-title":"Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.","volume":"59","author":"Li","year":"1999","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrc3770","article-title":"Going viral with cancer immunotherapy.","volume":"14","author":"Lichty","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.biomaterials.2016.06.024","article-title":"RNAi delivery by exosome-mimetic nanovesicles \u2013 Implications for targeting c-Myc in cancer.","volume":"102","author":"Lunavat","year":"2016","journal-title":"Biomaterials"},{"key":"B24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/mt.2011.303","article-title":"Microvesicle-associated AAV vector as a novel gene delivery system.","volume":"20","author":"Maguire","year":"2012","journal-title":"Mol. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ymthe.2017.01.004","article-title":"It\u2019s all in the delivery: improving AAV transfection efficiency with exosomes.","volume":"25","author":"Martin","year":"2017","journal-title":"Mol. Ther."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10043-0","article-title":"The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models.","volume":"10","author":"Mart\u00ednez-V\u00e9lez","year":"2019","journal-title":"Nat. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/sj.gt.3300978","article-title":"Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres.","volume":"6","author":"Matthews","year":"1999","journal-title":"Gene Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1182\/bloodadvances.2017010181","article-title":"Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors.","volume":"1","author":"Meliani","year":"2017","journal-title":"Blood Adv."},{"key":"B29","first-page":"5738","article-title":"Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.","volume":"58","author":"Miller","year":"1998","journal-title":"Cancer Res."},{"key":"B30","first-page":"271","article-title":"Simple methods for preparing recombinant adenoviruses for high-efficiency transduction of vascular cells.","volume":"30","author":"Nicklin","year":"1999","journal-title":"Methods Mol. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/jps.23556","article-title":"Evaluation of cell-penetrating peptide\/adenovirus particles for transduction of CAR-negative cells.","volume":"102","author":"Nigatu","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/cdli.11.2.351-357.2004","article-title":"Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States.","volume":"11","author":"Nwanegbo","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"B33","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1128\/JVI.2.10.1064-1075.1968","article-title":"Virus-receptor interaction in an adenovirus system.","volume":"2","author":"Philipson","year":"1968","journal-title":"J. Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biomaterials.2016.02.025","article-title":"Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy.","volume":"89","author":"Ran","year":"2016","journal-title":"Biomaterials"},{"key":"B35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.omtm.2018.03.008","article-title":"Enhanced production of exosome-associated AAV by overexpression of the tetraspanin CD9.","volume":"9","author":"Schiller","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.exphem.2004.03.010","article-title":"Gene transfer into human T lymphocytes and natural killer cells by Ad5\/F35 chimeric adenoviral vectors.","volume":"32","author":"Schroers","year":"2004","journal-title":"Exp. Hematol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/mt.2012.252","article-title":"Adenovirus expressing both thymidine kinase and soluble PD1 enhances antitumor immunity by strengthening CD8 T-cell response.","volume":"21","author":"Shin","year":"2013","journal-title":"Mol. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1128\/jvi.78.6.2666-2673.2004","article-title":"Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors.","volume":"78","author":"Sumida","year":"2004","journal-title":"J. Virol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1158\/0008-5472.CAN-16-1577","article-title":"Armed oncolytic adenovirus-expressing PD-L1 mini-body enhances antitumor effects of chimeric antigen receptor T Cells in solid tumors.","volume":"77","author":"Tanoue","year":"2017","journal-title":"Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/10717544.2018.1425774","article-title":"Extracellular vesicle-mimetic nanovesicles transport LncRNA-H19 as competing endogenous RNA for the treatment of diabetic wounds.","volume":"25","author":"Tao","year":"2018","journal-title":"Drug Deliv."},{"key":"B41","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/v2020468","article-title":"PEGylated adenoviruses: from mice to monkeys.","volume":"2","author":"Wonganan","year":"2010","journal-title":"Viruses"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20505-y","article-title":"Exosome-mimetic nanovesicles from hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo.","volume":"8","author":"Wu","year":"2018","journal-title":"Sci. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.ymthe.2019.07.019","article-title":"Recombinant adenovirus expressing a soluble fusion protein PD-1\/CD137L subverts the suppression of CD8+ T Cells in HCC.","volume":"27","author":"Zhang","year":"2019","journal-title":"Mol. Ther."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fbioe.2020.574007\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T05:48:37Z","timestamp":1600235317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fbioe.2020.574007\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":43,"alternative-id":["10.3389\/fbioe.2020.574007"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2020.574007","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]},"article-number":"574007"}}